SCHEMBL5199753

SCHEMBL5199753

O=c1[nH]c2ccccc2c2cnnn12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 11/20 0.50
HAVCR2 Q8TDQ0 2/20 0.49
HSD17B10 Q99714 1/20 0.49
GABRP O00591 1/20 0.47
GABRD O14764 1/20 0.47
GABRA1 P14867 1/20 0.47
GABRB1 P18505 1/20 0.47
GABRG2 P18507 1/20 0.47
GABRB3 P28472 1/20 0.47
GABRA5 P31644 1/20 0.47
GABRA3 P34903 1/20 0.47
GABRA2 P47869 1/20 0.47
GABRB2 P47870 1/20 0.47
GABRA4 P48169 1/20 0.47
GABRE P78334 1/20 0.47
GABRA6 Q16445 1/20 0.47
GABRG1 Q8N1C3 1/20 0.47
GABRG3 Q99928 1/20 0.47
GABRQ Q9UN88 1/20 0.47
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29646321 1.00 ADORA3 (0.50) ADORA3HAVCR2HSD17B10GABRPGABRD
SCHEMBL16370935 0.79 PDE7A (0.44) HSD17B10ALDH1A1
SCHEMBL30273100 0.76 ADORA3 (0.54) ADORA3HAVCR2HSD17B10GABRPGABRD
SCHEMBL8797846 0.76 ADORA3 (0.54) ADORA3HAVCR2HSD17B10GABRPGABRD
SCHEMBL9036763 0.72 ADORA3 (0.67) ADORA3HAVCR2HSD17B10
SCHEMBL11632879 0.72 ADORA3 (0.61) ADORA3HAVCR2HSD17B10GABRPGABRD
SCHEMBL30273095 0.71 ADORA3 (0.45) ADORA3HAVCR2HSD17B10GABRA5ALDH1A1
SCHEMBL11548167 0.70 ADORA3 (0.58) ADORA3HAVCR2HSD17B10GABRPGABRD
SCHEMBL515951 0.70 GPR3 (0.39) ALDH1A1
SCHEMBL11280041 0.69 ADORA3 (0.66) ADORA3HAVCR2HSD17B10GABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1809297-A1 IMIDAZO[1,5A]TRIAZOLO[1,5D]BENZODIAZEPINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE DISORDERS F. Hoffmann-Roche AG (CH) 2007-07-25 EP disclosed
EP-1807432-A1 HALOGEN SUBSTITUTED BENZODIAZEPINE DERIVATIVES F. Hoffmann-Roche AG (CH) 2007-07-18 EP disclosed
WO-2006045429-A1 HALOGEN SUBSTITUTED BENZODIAZEPINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2006-05-04 WO disclosed
WO-2006040038-A1 IMIDAZO [1, 5-A]TRIAZOLO[1, 5-D]BENZODIAZEPINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE DISORDERS F.HOFFMANN-LA ROCHE AG (CH) 2006-04-20 WO disclosed